Was Jim Cramer Right About Moderna (MRNA) Stock?
From Yahoo Finance: 2025-05-16 16:18:00
Jim Cramer expressed initial confidence in Moderna, Inc. (MRNA) in 2024 but later saw an 81.28% stock drop. The company specializes in mRNA-based vaccines, notably the COVID-19 vaccine. Cramer cited reasons for the stock’s decline, including negative press and FDA official resignations. Consider alternative AI stocks for higher returns.